Friday, September 4, 2015

VA on radiation hot seat

The failures of a prostate cancer program at the Philadelphia VA Medical Center and similar problems at 12 other VA hospitals has raised questions about whether the Veterans Health Administration can adequately oversee the safe use of radioactive materials in its health system. Wednesday, top radiation safety officials from the Department of Veteran's Affairs will testify before a panel of the U.S. Nuclear Regulatory Commission in advance of the agency's decision on how to address three apparent violations of federal radiation safety regulations.

VA on radiation hot seat

0 comments
Steven Reynolds, Director, Division of Nuclear Materials Safety, Region III (center), asks questions of the Veterans Administration Medical Center, Philadephia, staff during the US Nuclear Regulatory Commission hearings, Dec. 17, 2009, on the brachytherapy mistakes made at the Philadelphia Veterans Administration.
Steven Reynolds, Director, Division of Nuclear Materials Safety, Region III (center), asks questions of the Veterans Administration Medical Center, Philadephia, staff during the US Nuclear Regulatory Commission hearings, Dec. 17, 2009, on the brachytherapy mistakes made at the Philadelphia Veterans Administration.

The failures of a prostate cancer program at the Philadelphia VA Medical Center and similar problems at 12 other VA hospitals has raised questions about whether the Veterans Health Administration can adequately oversee the safe use of radioactive materials in its health system.

Wednesday, top radiation safety officials from the Department of Veteran’s Affairs will testify before a panel of the U.S. Nuclear Regulatory Commission in advance of the agency’s decision on how to address three apparent violations of federal radiation safety regulations.

The NRC could levy a fine against the VA for the problems or, in a more far reaching action, strip the VA of its ability to oversee radiation services at all 153 hospitals nationwide. The commission would then take on those duties or assign them to states, such as Pennsylvania and New Jersey that have that capability.

On May 25, the NRC released a preliminary finding that the VA had violated federal regulations in its 13 prostate brachytherapy programs in hospitals from Brooklyn, N.Y., and Jackson, Miss., to Seattle and Los Angeles. Prostate brachytherapy involves implanting dozens of tiny radioactive seeds into the acorn-sized gland to kill cancerous cells over several months. It is an effective treatment when done correctly.

But the records show that the Philadelphia VA’s program was deeply flawed from its earliest patients and that doctors and officials repeatedly missed chances to fix it. Those failures - which occurred from February 2002 until the program was shut down in June 2008 - prompted the NRC to take a deeper look at other brachytherapy programs in the VA system.

In March, the commission levied a $227,500 fine against the VA for a series of failures at its Philadelphia hospital’s prostate brachytherapy program that resulted in 97 veterans getting incorrect doses of radiation.

The commission also launched an investigation of the VA’s national radiation safety committee and its National Health Physics Program, which oversee the use of radiation across the Veterans Health Administration.

The nuclear agency found the three apparent violations extended beyond Philadelphia to other VA hospitals centers. They involve failing to develop procedures to ensure that care is carefully laid out, verify that the procedure goes according to plan in at least four medical centers; and not reporting one incident of improper dosing within 24 hours, as required.

NRC officials said it was worrisome that those VA safety organizations failed to identify problems such as underdosing of patients, accidentally implanting radioactive seeds in patient's bladders, and delivering excessive radiation doses to patients' rectums and other healthy tissue.

The problems at the Philadelphia VA also promoted the Veterans Health Administration to change its oversight of programs that use radiation to treat cancer at its hospital said Charles Anderson, chair of the VA National Radiation Safety Committee.

“These changes have come about because they realized the weakness that was exposed by Philadelphia,” Anderson said. 

Calling the failures in the brachytherapy program at the Philadelphia VA hospital a “game change,” Anderson added, 
“our level of oversight of our radiation safety programs has profoundly increased from what we had before.”

To check out more Check Up items go to www.philly.com/checkup.

Check out other stories on the prostate brachytherapy program at the Philadelphia VA:

Sunday, June 21, 2009
Feds see wider woes in VA's cancer errors

Sunday, July 19, 2009 
VA radiation errors laid to offline computer

Sunday, August 9, 2009
VA's prostate treatment woes began at Penn;
Prior to the VA program, leading brachytherapists said the Penn doctors performing the radioactive seed implants lacked the proper skills and safeguards.

Sunday, November 15, 2009
VA clinic troubles bring few penalties;
Despite poor care in the Phila. prostate program, the agency has only slapped a few hands

Wednesday, November 25, 2009
Claims against Phila. VA up to $58 million

Thursday, Mar. 18, 2010
NRC fines Phila. VA $227,500 over prostate care

Tuesday, May 4, 2010
Mistakes, little oversight cited for Phila. VA prostate cancer treatment

Wednesday, May 26, 2010
NRC finds apparent violations at 13 VA hospitals

0 comments
We encourage respectful comments but reserve the right to delete anything that doesn't contribute to an engaging dialogue.
Help us moderate this thread by flagging comments that violate our guidelines.

Comment policy:

Philly.com comments are intended to be civil, friendly conversations. Please treat other participants with respect and in a way that you would want to be treated. You are responsible for what you say. And please, stay on topic. If you see an objectionable post, please report it to us using the "Report Abuse" option.

Please note that comments are monitored by Philly.com staff. We reserve the right at all times to remove any information or materials that are unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane, indecent or otherwise objectionable. Personal attacks, especially on other participants, are not permitted. We reserve the right to permanently block any user who violates these terms and conditions.

Additionally comments that are long, have multiple paragraph breaks, include code, or include hyperlinks may not be posted.

Read 0 comments
 
comments powered by Disqus
About this blog

Check Up is a blog for savvy health consumers, covering the latest developments, discoveries, and debates from the Philadelphia area and beyond.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Charlotte Sutton Health and Science Editor, Philadelphia Inquirer
Tom Avril Inquirer Staff Writer, heart health and general science
Stacey Burling Inquirer Staff Writer, neuroscience and aging
Marie McCullough Inquirer Staff Writer, cancer and women's health
Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
letter icon Newsletter